|
NDST2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.8561002148092E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.1121004117598E-10 |
| Normal-vs-Stage2 |
3.476800E-03 |
| Normal-vs-Stage3 |
2.443900E-04 |
| Normal-vs-Stage4 |
6.27180000000171E-05 |
| Stage1-vs-Stage2 |
2.936400E-01 |
| Stage1-vs-Stage3 |
2.635800E-02 |
| Stage1-vs-Stage4 |
3.337000E-01 |
| Stage2-vs-Stage3 |
6.128600E-01 |
| Stage2-vs-Stage4 |
8.380400E-01 |
| Stage3-vs-Stage4 |
3.835400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.51169995702361E-09 |
| Normal-vs-AfricanAmerican |
1.90232999999207E-05 |
| Normal-vs-Asian |
9.61060000026492E-07 |
| Caucasian-vs-AfricanAmerican |
2.306800E-01 |
| Caucasian-vs-Asian |
4.235600E-02 |
| AfricanAmerican-vs-Asian |
1.504010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.12760000009682E-07 |
| Normal-vs-Female |
1.11689546500315E-11 |
| Male-vs-Female |
9.177700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.515600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.08800002340814E-09 |
| Normal-vs-Age(61-80Yrs) |
8.95130000122535E-08 |
| Normal-vs-Age(81-100Yrs) |
8.309900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.737400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.771200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.329000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.930800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.608800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.214200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.08709946494901E-10 |
| Normal-vs-Grade 2 |
2.41830000469179E-10 |
| Normal-vs-Grade 3 |
2.4945000000054E-06 |
| Normal-vs-Grade 4 |
4.596500E-04 |
| Grade 1-vs-Grade 2 |
1.662270E-02 |
| Grade 1-vs-Grade 3 |
9.199100E-04 |
| Grade 1-vs-Grade 4 |
2.942900E-03 |
| Grade 2-vs-Grade 3 |
3.969800E-02 |
| Grade 2-vs-Grade 4 |
1.854800E-01 |
| Grade 3-vs-Grade 4 |
8.934600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.22789564574555E-11 |
| Normal-vs-ccB subtype |
5.812800E-04 |
| ccA subtype-vs-ccB subtype |
1.379260E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.90410000491903E-08 |
| Normal-vs-N1 |
3.601500E-02 |
| N0-vs-N1 |
4.639400E-01 |
|
|
